These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2007968)

  • 1. Statistical process control for the pharmaceutical industry.
    Gershon M
    J Parenter Sci Technol; 1991; 45(1):41-50. PubMed ID: 2007968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control.
    Gowen AA; O'Donnell CP; Cullen PJ; Bell SE
    Eur J Pharm Biopharm; 2008 May; 69(1):10-22. PubMed ID: 18164926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical tools for setting in-process acceptance criteria.
    Seely RJ; Munyakazi L; Haury J
    Dev Biol (Basel); 2003; 113():17-25. PubMed ID: 14620848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies.
    Roggo Y; Chalus P; Maurer L; Lema-Martinez C; Edmond A; Jent N
    J Pharm Biomed Anal; 2007 Jul; 44(3):683-700. PubMed ID: 17482417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts.
    Skibsted ET; Boelens HF; Westerhuis JA; Witte DT; Smilde AK
    J Pharm Biomed Anal; 2006 Apr; 41(1):26-35. PubMed ID: 16289623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
    Gooding OW
    Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personnel training: a key aspect of a quality program in the chemical process industry.
    Kauffman JM; Weiler ED
    Qual Assur; 1993 Dec; 2(4):359-63. PubMed ID: 7952971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: a review.
    Tomba E; Facco P; Bezzo F; Barolo M
    Int J Pharm; 2013 Nov; 457(1):283-97. PubMed ID: 24016743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From zero to teamwork: a manufacturing journey.
    Williams MK
    Hosp Mater Manage Q; 1996 Feb; 17(3):67-71. PubMed ID: 10154939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalidation in pharmaceutical analysis. Part I. Fundamentals and critical discussion.
    Grdinić V; Vuković J
    J Pharm Biomed Anal; 2004 May; 35(3):489-512. PubMed ID: 15137975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the applications of statistical process control in health care.
    Adeoti OA
    Niger J Med; 2009; 18(1):25-8. PubMed ID: 19485142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of outcomes measurement in performance improvement efforts.
    Rudman WJ
    Top Health Inf Manage; 1998 Feb; 18(3):1-7. PubMed ID: 10176535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Just-in-time: maximizing its success potential.
    Johnston SK
    Hosp Mater Manage Q; 1990 Aug; 12(1):22-9. PubMed ID: 10105557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a quality improvement program.
    Nackel JG; Collier TA
    J Soc Health Syst; 1989 May; 1(1):85-100. PubMed ID: 2491236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.